An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.

Launched by UNIVERSITY OF AUCKLAND, NEW ZEALAND · Oct 24, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a device called the LumAssure, which helps measure skin conditions to see if they are benign (not harmful) or cancerous. The goal is to find out how accurately this device can tell the difference between these types of skin conditions in adults. Participants in the study will include men and women aged 18 and older who are having their skin checked by a doctor, such as a dermatologist or plastic surgeon. They will have their skin examined, and the LumAssure device will be used to take measurements of their skin conditions.

To be eligible for this study, participants need to be able to give their consent, be at least 18 years old, and be willing to have their skin condition measured with the LumAssure device. They should also be seeing a qualified specialist for a skin examination or tissue removal. However, if someone has a tattoo on the area being measured or has skin conditions near their eyes, they won’t be able to participate. Overall, participants can expect to receive a thorough skin assessment and contribute to research that may improve how skin conditions are diagnosed in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Able to provide informed consent
• • Male or female aged 18 years or over.
• • Willing to undergo a LumAssure device measurement on at least 1 skin condition
• • (For Standard of Care patients): are undergoing a skin examination and/or tissue excision by a qualified specialist
• • (For Healthy volunteers): are attending a skin check at a study clinic
• Exclusion Criteria:
• • Tattoo on the skin condition to be measured
• • Skin conditions on or directly around the eye area